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Immunisation is the most cost-effective and successful public 
health intervention of all time, saving more than two million 
lives each year.1 There are currently more than 25 vaccine-
preventable diseases, and the number of diseases that can be 
prevented by vaccines is growing as a result of advances in 
biomedical research, science and technology.
The introduction of immunisation programmes worldwide, 
following the initiation of the Expanded Programme on 
Immunisation (EPI) by the World Health Organization 
(WHO) in 1974, has resulted in significant accomplishments. 
In 1977 smallpox was eradicated after a 10-year campaign.1
Poliomyelitis will be the next disease in line to be eradicated. 
Since the Global Polio Eradication Initiative was launched in 
1988, the incidence of poliomyelitis has decreased by more 
than 99% and about 5 million people have escaped paralysis 
by the wild poliovirus.1,2 In addition, the WHO estimates that 
measles deaths worldwide fell by a remarkable 74% between 
2000 and 2007, from 750 000 to 197 000. It is estimated that 
during this period 11 million deaths were averted globally as a 
result of measles control activities.3 Furthermore, in 2007 global 
coverage for the third dose of the diphtheria-tetanus-pertussis 
combination vaccine was 81%, up from 20% in 1980.1
However, despite these tremendous advances, more than 24 
million children still do not have access to basic immunisation 
services, including 7.3 million in sub-Saharan Africa.1 Those 
who miss out on routine vaccination programmes tend to be 
people living in remote locations, urban slums and border 
areas. Such hard-to-reach populations also include displaced 
populations, those lacking awareness or motivation to be 
vaccinated, and those who refuse to be vaccinated. The 
consequence of not having access to vaccines, or not being 
immunised, is the untimely death of 2 - 3 million people each 
year from vaccine-preventable diseases.1 A large proportion of 
these deaths occur in Africa. 
Africa lags far behind other continents in the uptake of 
life-saving vaccines. Most children in Africa have access to 
only 6 - 8 vaccines. In contrast, a child born in a high-income 
country such as the USA has access to over 15 vaccines.4 This 
vaccine gap is widening by the day. There is an urgent need 
to reduce morbidity and mortality from vaccine-preventable 
diseases in Africa by increasing awareness of the benefits of 
vaccines, promoting the uptake of existing EPI vaccines, and 
advocating for the inclusion of new vaccines into national 
EPI programmes. In this regard, it is pleasing to note that the 
South African Health Department has introduced the rotavirus 
vaccine and the conjugated pneumococcal vaccine into the 
national EPI programme. 
Effective communication should be an essential component 
of the EPI in Africa, because it could mobilise resources 
for national immunisation programmes, encourage wide 
participation and ownership of immunisation services among 
all stakeholders in every African country, and lead to positive 
changes in knowledge, behaviour and attitudes towards 
vaccines and immunisation in Africa.
These are the reasons why the Vaccines for Africa (VACFA) 
website (www.vacfa.com) was launched on 31 March 2009. The 
website is intended to be an interactive forum for the exchange 
of accurate, up-to-date and evidence-based information on 
vaccines and immunisation practices relevant to Africa. As 
such, it would be a ‘one-stop shop’ of targeted information 
for health professionals, policymakers, programme managers 
and the general public. VACFA complements the work of 
international immunisation advocacy organisations such as 
WHO, UNICEF, GAVI Alliance and other agencies in bringing 
relevant up-to-date information to decision makers in Africa 
in order to facilitate 
timely evidence-informed 
decisions.
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